Magnetic resonance imaging with diffusion-weighted imaging in the evaluation of thyroid-associated orbitopathy: getting below the tip of the iceberg
详细信息 查看全文
- 作者：Letterio Salvatore Politi (1) (2)
Claudia Godi (1) (2)
Gabriella Cammarata (3)
Alessandro Ambrosi (2)
Antonella Iadanza (1)
Roberto Lanzi (4)
Andrea Falini (1) (2)
Stefania Bianchi Marzoli (3) - 关键词：Thyroid ; associated ophthalmopathy ; Orbit ; ADC ; Extraocular muscle inflammation
- 刊名：European Radiology
- 出版年：2014
- 出版时间：May 2014
- 年：2014
- 卷：24
- 期：5
- 页码：1118-1126
- 全文大小：2,629 KB
- 参考文献：1. Dickinson AJ, Perros P (2001) Controversies in the clinical evaluation of active thyroid-associated orbitopathy: use of a detailed protocol with comparative photographs for objective assessment. Clin Endocrinol (Oxf) 55:283-03 CrossRef
2. Bartalena L, Tanda ML (2009) Graves' ophthalmopathy. N Engl J Med 360:994-001 CrossRef
3. Parmar H, Ibrahim M (2008) Extrathyroidal manifestations of thyroid disease: thyroid ophthalmopathy. Neuroimaging Clin N Am 18:527-36 CrossRef
4. El-Kaissi S, Frauman AG, Wall JR (2004) Thyroid-associated ophthalmopathy: a practical guide to classification, natural history and management. Intern Med J 34:482-91 CrossRef
5. Carl A, Pedersen IB, Knudsen N et al (2011) Epidemiology of subtypes of hyperthyroidism in Denmark: a population-based study. Eur J Endocrinol 164:801-09 CrossRef
6. Abraham-Nordling M, Bystrom K, Torring O et al (2011) Incidence of hyperthyroidism in Sweden. Eur J Endocrinol 165:899-05 CrossRef
7. Eckstein A, Schittkowski M, Esser J (2012) Surgical treatment of Graves' ophthalmopathy. Best Pract Res Clin Endocrinol Metab 26:339-58 CrossRef
8. Soeters M, van Zeijl C, Boelen A et al (2011) Optimal management of Graves orbitopathy: a multidisciplinary approach. Neth J Med 69:302-08
9. Boboridis K, Bunce C (2011) Surgical orbital decompression for thyroid eye disease. Cochrane Database Syst Rev CD007630
10. Mourits M, Koornneef L, Wiersinga W, Prummel M, Berghout A, van der Gaag R (1989) Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach. Br J Ophthalmol 73:639-44 CrossRef
11. Hosten N, Sander B, Cordes M, Schubert CJ, Schorner W, Felix R (1989) Graves ophthalmopathy: MR imaging of the orbits. Radiology 172:759-62
12. Sillaire I (2003) Graves' ophthalmopathy: usefulness of T2 weighted muscle signal intensity. J Radiol 84:139-42
13. Prummel MF, Gerding MN, Zonneveld FW, Wiersinga WM (2001) The usefulness of quantitative orbital magnetic resonance imaging in Graves' ophthalmopathy. Clin Endocrinol 54:205-09 CrossRef
14. Taoka T, Iwasaki S, Uchida H (2000) Enhancement pattern of normal extraocular muscles in dynamic contrast-enhancement MR imaging with suppression. Acta Radiol 41:211-16 CrossRef
15. Taoka T (2005) Evaluation of extraocular muscles using dynamic contrast enhanced MRI in patients with chronic thyroid orbitopathy. J Comput Assist Tomogr 29:115-20 CrossRef
16. Cakirer S (2004) Evaluation of extraocular muscles in the edematous phase of Graves ophthalmopathy on contrast-enhanced fat-suppressed magnetic resonance imaging. J Comput Assist Tomogr 28:80-6 CrossRef
17. Sepahdari AR, Aakalu V, Setabutr P, Shiehmorteza M, Naheedy JH, Mafee MF (2010) Indeterminate orbital masses at MR imaging. Radiology 256:554-64 CrossRef
18. Politi LS, Forghani R, Godi C et al (2010) Ocular adnexal lymphoma: diffusion-weighted MR Imaging for differential diagnosis and therapeutic monitoring. Radiology 256:565-74 CrossRef
19. Razek A, Elkhamary S, Mousa A (2011) Differentiation between benign and malignant orbital tumors at 3-T diffusion MR-imaging. Neuroradiology 53:517-22 CrossRef
20. Sepahdari AR, Kapur R, Aakalu VK, Villablanca JP, Mafee MF (2012) Diffusion-weighted imaging of malignant ocular masses: initial results and directions for further study. Am J Neuroradiol 33:314-19 CrossRef
21. Laurberg P, Berman DC, Bülow Pedersen I, Andersen S, Carlé A (2012) Incidence and clinical presentation of moderate to severe Graves' orbitopathy in a Danish population before and after iodine fortification of salt. J Clin Endocrinol Metab 97:2325-332 CrossRef
22. Kirsch E, Kaim AH, Oliveira MGD, Gv A (2010) Correlation of signal intensity ratio on orbital MRI-TIRM and clinical activity score as a possible predictor of therapy response in Graves' orbitopathy-a pilot study at 1.5?T. Neuroradiology 52:91-7 CrossRef
23. Gon?alves AC, Silva LN, Gebrim EM, Monteiro ML (2012) Quantification of orbital apex crowding for screening of dysthyroid optic neuropathy using multidetector CT. Am J Neuroradiol 33:1602-607 CrossRef
24. Müller-Forell W, Kahaly GJ (2012) Neuroimaging of Graves' orbitopathy. Best Pract Res Clin Endocrinol Metab 26:259-71 CrossRef
25. Bijlsma WR (2006) Radiologic measurement of extraocular muscle volumes in patients with Graves' orbitopathy: a review and guideline. Orbit 25:83-1 CrossRef - 作者单位：Letterio Salvatore Politi (1) (2)
Claudia Godi (1) (2)
Gabriella Cammarata (3)
Alessandro Ambrosi (2)
Antonella Iadanza (1)
Roberto Lanzi (4)
Andrea Falini (1) (2)
Stefania Bianchi Marzoli (3)
1. Neuroradiology Department and Neuroradiology Research Unit, San Raffaele Scientific Institute, Via Olgettina 60, 20132, Milan, Italy
2. Università Vita-Salute San Raffaele, Milan, Italy
3. Neurophthalmology Service, Ophthalmology Department, IRCCS Istituto Auxologico Italiano, Milan, Italy
4. Endocrinology Unit, Department of Internal Medicine, San Raffaele Scientific Institute, Milan, Italy - ISSN：1432-1084
文摘
Objectives To compare extraocular muscles (EOMs) T2, post-contrast T1 (T1Gad) signal intensity ratios (SIRs) and normalized-apparent diffusion coefficient (n-ADC) values in patients with thyroid-associated orbitopathy (TAO) at different phases of activity and severity and correlate MRI modifications to clinical evolution during follow-up. Methods A total of 74 TAO patients were classified as active or inactive on the basis of the clinical activity score (CAS). Severity of EOM impairment was evaluated by assigning a functional score to each rectus. T2, T1Gad SIRs and n-ADC of EOMs were compared in patients with active inflammation, those with inactive disease and 26 healthy controls, and correlated with clinical scores. MRI parameter variation was correlated with clinical modifications during follow-up. Results All MRI parameters in TAO EOMs were significantly higher than in healthy subjects and correlated with muscle dysfunction and CAS. EOMs of active patients showed higher T2 and T1Gad SIRs than those with inactive disease. The T2 SIR and n-ADC of normally functioning TAO EOMs were higher than those of healthy controls. SIRs decreased in clinically improved and clinically stable EOMs after therapy. Conclusions T2 SIR, T1Gad SIR and n-ADC are objective measures of activity and severity of EOMs in TAO patients. MRI shows clinically silent muscle involvement and modifications. Key Points -MRI and DWI measures are objective, quantitative parameters of TAO activity and severity -MRI and DWI measures significantly correlate with clinical scores in TAO patients -MRI and DWI can identify clinically silent inflammation of deep orbital structures -MRI and DWI can depict subclinical modifications during follow-up -MRI and DWI may aid clinicians in choosing the most appropriate treatment